文献速递慢性静脉疾病静脉血栓栓塞

女性静脉性溃疡患者髂股静脉支架置入的结局

Outcomes of iliofemoral venous stenting in women with venous ulcers.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-03-30

该回顾性队列研究纳入50例接受髂静脉支架置入的非愈合性或复发性静脉性溃疡女性患者,评估支架置入及先前浅静脉干预的作用。结果显示60%溃疡完全愈合,愈合与溃疡大小相关,先前消除浅静脉反流与愈合改善相关。

要点

  • 髂静脉支架置入后60%溃疡完全愈合,其中80%在1年内愈合。
  • 溃疡不愈合与溃疡面积>7 cm²相关(OR 0.96,95%CI 0.92-0.99,P≤.03)。
  • 先前消除同侧浅静脉反流与支架后愈合改善相关(OR 5.06,95%CI 0.942-27.21,P≤.06)。

核心结论

  • 静脉性溃疡患者为慢性疾病,多数在支架置入前2至4年接受过浅静脉干预。
  • 髂静脉支架置入后60%溃疡完全愈合,其中80%在1年内愈合。
  • 溃疡愈合与溃疡大小直接相关,且先前消除浅静脉反流与愈合改善相关。

研究设计与样本

  • 回顾性队列分析,纳入2019年11月至2024年12月前瞻性收集的数据。
  • 研究对象为接受髂静脉支架置入的非愈合性或复发性静脉性溃疡女性患者,共50例。
  • 评估人口学特征、修订版静脉临床严重程度评分、视觉模拟评分、浅静脉手术情况、溃疡大小、持续时间、愈合时间、再干预率及类型。

主要发现

  • 平均年龄66.7±12.6岁,平均体重指数37.8±8.2。
  • 溃疡位于左肢36例,右肢14例;初诊时60%有活动性溃疡,40%有慢性静脉功能不全症状。
  • 溃疡诊断前持续时间为4.4±4.2个月,17例报告溃疡复发,平均溃疡面积23.7±37.2 cm²。
  • 30例溃疡在支架置入后愈合,19例(38%)在支架置入后≤2年不愈合,1例失访。
  • 平均愈合时间261.9±301.6天;支架置入前同侧浅静脉干预36例,对侧25例;再干预9例(18%),平均再干预时间18.3±18.3个月。

关键数值与推荐

  • 多因素分析显示不愈合与溃疡面积>7 cm²相关(OR 0.96,95%CI 0.92-0.99,P≤.03)。
  • 先前消除同侧浅静脉反流与支架后愈合改善相关(OR 5.06,95%CI 0.942-27.21,P≤.06)。
  • 支架类型:Venovo 30例,Abre 19例,Wallstent 1例。

临床怎么用

  • 对于非愈合性或复发性静脉性溃疡女性患者,髂静脉支架置入可促进溃疡愈合。
  • 溃疡面积>7 cm²提示愈合可能性降低,需密切随访。
  • 支架置入前消除同侧浅静脉反流可能改善愈合。

局限性

  • 回顾性队列分析,样本量50例,可能存在选择偏倚。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The efficacy of suprainguinal venous interventions in the management of venous ulceration, after the elimination of infrainguinal superficial venous reflux, is currently ill-defined. The purpose of this investigation was to assess the role of venous stenting and prior infrainguinal superficial vein interventions in the management of patients with nonhealing and/or recurrent venous ulcers. METHODS: A retrospective cohort analysis of prospectively collected data from November 2019 to December 2024 on nonhealing or recurrent venous ulcer female patients treated with iliac vein stenting. Patient demographics, Revised Venous Clinical Severity Score, visual analog scale scores, number and types of superficial vein procedures in the index and contralateral limbs before stenting, ulcer size, duration, time to healing, reintervention rates, and types of reinterventions were assessed. RESULTS: Fifty patients met the inclusion criteria. All were female with an average age of 66.7 ± 12.6 years and body mass index of 37.8 ± 8.2. The average Revised Venous Clinical Severity Score was 11.7 ± 4.8 on the left and 9.2 ± 4.3 on the right. Ulcers were in the left limb in 36 and the right limb in 14. The primary symptom on initial presentation was an active ulcer in 60% of patients. The remaining 40% presented with symptoms of chronic venous insufficiency secondary to symptomatic infrainguinal superficial vein reflux. In these patients, the time from initial patient encounter to the development of an ulcer was 617 ± 1353 days. Ulcer duration before diagnosis was 4.4 ± 4.2 months and 17 patients reported the ulcers were recurrent. Average ulcer size was 23.7 ± 37.2 cm2. Ulcers healed in 30 patients after stenting. Nonhealing was seen in 19 patients (38%) at ≤2 years after stenting; one patient was lost to follow-up. Multivariate analysis indicated that nonhealing was associated with ulcer size of >7 cm2 (odds ratio [OR], 0.96; 95% confidence interval, 0.92-0.99; P ≤ .03) and suggested that prior elimination of infrainguinal superficial vein reflux in the index limb was associated with improved healing after stenting (OR, 5.06; 95% confidence interval, 0.942-27.21; P ≤ .06). Average time to healing was 261.9 ± 301.6 days. Before stenting, superficial interventions in the index limb were performed in 36 patients and contralateral limbs in 25 patients. Average area reduction on intravascular ultrasound examination was 66.2 ± 11.1 cm2, stent diameters reduction was 15.3 ± 1.2 mm, stent lengths reduction was 133.6 ± 25 mm, and the average number of reinterventions was 9 out of the 50 patients (18%). The average time to reintervention was 18.3 ± 18.3 months. Stent types were 30 Venovo, 19 Abre, and 1 Wallstent. CONCLUSIONS: Venous ulcer patients have chronic disease, with the majority reporting undergoing superficial interventions for 2 to 4 years before stenting. After iliac vein stenting, 60% of ulcers demonstrated complete ulcer healing, with 80% of those healed by 1 year. Ulcer healing is directly related to ulcer size and is associated with improved healing when infrainguinal superficial reflux is eliminated.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Pappas CP, Lakhanpal G, Kennedy R, et al. Outcomes of iliofemoral venous stenting in women with venous ulcers. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41921606. doi:10.1016/j.jvsv.2026.102492

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。